Ken Griffin Moderna, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $44.7 Million - $87.9 Million	702,300 Added 38.7%	2,516,800 $168 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $33.6 Million - $55.3 Million	-331,700 Reduced 15.46%	1,814,500 $215 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $16.5 Million - $22.3 Million	-192,900 Reduced 8.25%	2,146,200 $229 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $24.4 Million - $36.7 Million	-351,200 Reduced 13.05%	2,339,100 $233 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $80.3 Million - $105 Million	832,700 Added 44.83%	2,690,300 $278 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $5.59 Million - $7.58 Million	-47,200 Reduced 2.48%	1,857,600 $226 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $325 Million - $471 Million	-2,392,200 Reduced 55.67%	1,904,800 $293 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $265 Million - $471 Million	2,241,900 Added 109.09%	4,297,000 $772 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $28.1 Million - $46.2 Million	237,800 Added 13.09%	2,055,100 $243 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.